Cargando…
Evaluation of RNA Amplification Methods to Improve DC Immunotherapy Antigen Presentation and Immune Response
Dendritic cells (DCs) transfected with total amplified tumor cell RNA have the potential to induce broad antitumor immune responses. However, analytical methods required for quantitatively assessing the integrity, fidelity, and functionality of the amplified RNA are lacking. We have developed a seri...
Autores principales: | Slagter-Jäger, Jacoba G, Raney, Alexa, Lewis, Whitney E, DeBenedette, Mark A, Nicolette, Charles A, Tcherepanova, Irina Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817939/ https://www.ncbi.nlm.nih.gov/pubmed/23653155 http://dx.doi.org/10.1038/mtna.2013.18 |
Ejemplares similares
-
Multi-functional cytotoxic T cell expansion correlates with overall survival after administration of autologous dendritic cell immunotherapy in renal cell cancer patients
por: DeBenedette, M, et al.
Publicado: (2013) -
Multiplex RT-PCR Amplification of HIV Genes to Create a Completely
Autologous DC-Based Immunotherapy for the Treatment of HIV Infection
por: Tcherepanova, Irina, et al.
Publicado: (2008) -
A review of the clinical experience with CMN-001, a tumor RNA loaded dendritic cell immunotherapy for the treatment of metastatic renal cell carcinoma
por: DeBenedette, Mark, et al.
Publicado: (2023) -
Survival with AGS-003, an autologous dendritic cell–based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC): Phase 2 study results
por: Amin, Asim, et al.
Publicado: (2015) -
Assessing the impact of AGS-004, a dendritic cell-based immunotherapy, and vorinostat on persistent HIV-1 Infection
por: Gay, Cynthia L., et al.
Publicado: (2020)